Bristol-Myers Squibb Co. (NYSE: BMY): By the end of last trading session, the shares of Bristol Myers Squibb (NYSE: BMY) soared US$2.34 (or 5.31%) to US$46.40 with 25.35 million shares exchanged hands, compared to daily average volume of 10.39 ...

Sprycel: Developed by Bristol Myers Squibb Co. (NYSE:BMY), Sprycel was approved in 2006 as a second-line treatment for patients who had Philadelphia chromosome-positive (Ph+) ALL or Ph+ CML, and had resistance to prior therapy.

Capstone Turbine Corporation (NASDAQ:CPST) shares jumped 5.08% to $0.904. The company, on April 8, announced that it received an order for thirty-four liquid fuel C30s for use in DesignLine'sEco Saver IV range extended electric buses.

Saed Hindash/The Star-Ledger. Two drugs from Bristol-Myers Squibb Co. shrank tumors in as many as half of patients with advanced melanoma, according to early research that may pave the way for cocktails that trigger the immune system to destroy cancer.

A drug combination developed by Bristol-Myers Squibb Co. that uses the body's immune system to fight cancer has shown better outcomes in melanoma patients than if only one drug were administered.

Bristol-Myers Squibb Company (NYSE: BMY) will present at Bank of America Merrill Lynch Health Care Conference on Wednesday, May 15, 2013, in Las Vegas.

Merus Labs International Inc. (NASDAQ: MSLI) (TSX: MSL) is a specialty pharmaceutical company focused on the licensing and acquisition of recognized products that are under-promoted from larger pharmaceuticals.

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Bristol-Myers Squibb Company (NYSE:BMY), Sanofi (NYSE:SNY), AbbVie (NYSE:ABBV) ...

Bristol-Myers Squibb Company (NYSE: BMY) will present at the UBS Global Health Care Conference on Tuesday, May 21, 2013, in New York City.

(RTTNews.com) - Biopharmaceutical company Bristol-Myers Squibb Co. ( BMY ) Thursday reported a plunge in profit for the first quarter, as sales dropped 27 percent after U.S.